Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 26 | 295 | 72 | 42 |
| TOTAL | $5 | $26 | $295 | $72 | $316 |
| Non-Current Assets | |||||
| Intangibles | 134 | 113 | 76 | 47 | 10 |
| TOTAL | $134 | $113 | $76 | $47 | $10 |
| Total Assets | $139 | $139 | $371 | $119 | $326 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 667 | 330 | 1,464 | 1,155 | 655 |
| Other current liabilities | 411 | 1,015 | 39 | 0 | N/A |
| TOTAL | $1,931 | $3,244 | $3,668 | $3,278 | $2,268 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13 | 90 | 193 | 496 | 62 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,931 | $3,244 | $3,668 | $3,278 | $2,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,882 | 166,493 | 123,502 | 110,841 | 100,750 |
| Common Shares | 87 | 145 | 123 | 111 | 98 |
| Retained earnings | -18,921 | -15,699 | -11,227 | -8,754 | -4,722 |
| Other shareholders' equity | 0 | -636 | -591 | -397 | 888 |
| TOTAL | $-1,792 | $-3,105 | $-3,297 | $-3,158 | $-1,941 |
| Total Liabilities And Equity | $139 | $139 | $371 | $119 | $326 |